reverse-phase HPLC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-08-24. Anything still debated is marked as such rather than presented as settled.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
| Property | Value | Notes |
|---|---|---|
| Common route | Intranasal | Also injected in some animal work |
| Solubility class | Freely soluble in water | Solid form is hygroscopic |
| Typical storage | About -20 degrees Celsius | Keep desiccated and dark |
| Purity method | Reverse-phase HPLC | Reported as area percent |
| Confirmatory method | Mass spectrometry | Verifies expected molecular mass |
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
=== High androgen levels === CPA is used as an antiandrogen to treat high androgen levels and associated symptoms such as masculinization due to conditions like polycystic ovary syndrome (PCOS) and congenital adrenal hyperplasia (CAH) in women. It is almost always combined with an estrogen, such as ethinylestradiol, when it is used in the treatment of PCOS in women.
In any case, findings that bicalutamide helps to preserve body weight and lean body mass in castrated male rats also could not be explained by preservation of estrogen levels. Aside from muscle, bicalutamide has also been found to act not as an AR silent antagonist but as a weak partial agonist of the receptor with SARM-like activity in AR-positive MDA-MB-453 breast cancer cells. Whereas a pure AR antagonist should have no effect, bicalutamide regulated almost 50% of 189 DHT-responsive genes in this cell line and induced these genes around 25% as effectively as the highest tested concentration of DHT. DHT and SARMs like enobosarm and GTx-027 inhibit the proliferation of AR-expressing MDA-MB-231 breast cancer cells, whereas findings for bicalutamide are conflicting. Bicalutamide has also shown SARM-like or weak partial agonist activity in certain other in vitro AR bioassays. A very high (50 mg/kg) dose of bicalutamide has been found to suppress testosterone levels by about 91% in gonadally intact male mice, which was to a similar degree as the SARM MK-4541. These findings suggest that bicalutamide at very high doses may have antigonadotropic effects that may be mediated by SARM-like activity. Conversely however, lower doses of bicalutamide (1–25 mg/kg) have not been found to affect testosterone levels in gonadally intact male rats, and similar or higher doses of bicalutamide (20–100 mg/kg) did not affect testosterone levels in gonadally intact male dogs.
Illegal drugs can be counterfeited easily because no standards or regulations govern them or their packaging though some examples of illegal drugs are sold under "brand names" to indicate certain standards or dosage levels were being adhered to, as in the case of 1960s-era LSD, which was sold with patterns or logos printed on blotter paper. These illegal "brands" can also be counterfeited by drug dealers who want to be able to sell their products at higher prices. Counterfeit illegal and recreational drugs range from products which do not contain any active ingredients, as in cases where lactose powder is sold as heroin, or dried herbs such as oregano are sold as cannabis, to cases where the active ingredients are "cut" with a diluent (as in cases where cocaine is mixed with lactose powder), and cases where the claimed active ingredients are substituted by something cheaper (e.g., when methamphetamine is sold as cocaine). The use of diluents in illegal drugs reduces the potency of the drugs and makes it hard for users to determine the appropriate dosage level. Diluents include "foodstuffs (flour and baby milk formula), sugars (glucose, lactose, maltose, and mannitol), and inorganic materials such as powder." The diluents used, often depend on the way drug purchasers consume particular drugs. Drug dealers selling heroin to users who inject, dilute the drug with different products from dealers selling to users who smoke, or insufflate the drug. Diluents which can easily form a solution with water for injecting heroin can be problematic for users who are sniffing the powder.
=== Exercise fatigue === L-Ornithine supplementation has been shown to attenuate fatigue in subjects in placebo-controlled studies using a cycle ergometer. The results suggest that L-ornithine may exert an antifatigue effect by increasing the efficiency of energy consumption and promoting the excretion of ammonia.
Sources: en.wikipedia.org
=== Commercial applications === According to a 2010 survey, the three primary uses of the 26,000 low-energy particle accelerators operating worldwide are radiotherapy (44%), ion implantation (41%), and industrial processing (9%). HVEC made foundational contributions to all three. The company's compact Van de Graaff generators were among the first artificial radiation sources commercially available for cancer treatment. Radiation physicist Milford Schulz called them "truly milestones in the progress of radiotherapy." The first medical linear accelerator—now the dominant technology in cancer treatment—was assembled at Stanford using a retrofitted HVEC machine. Ion implantation, pioneered at HVEC's Ion Physics Corporation, became standard practice in semiconductor manufacturing by the late 1970s. The technique enabled MOS integrated circuits that dominate modern electronics. Radiation crosslinking, developed at Electronized Chemicals Corporation, produced heat-shrink tubing and films now ubiquitous in electrical wiring and food packaging.
== Awards and honours == 2004 CWA Ian Fleming Steel Dagger Award shortlist for Dead I Well May Be 2007 Audie Award for Best Thriller/Suspense for The Dead Yard. 2008 Young Hoosier Award and Beehive Award shortlist for The Lighthouse Land 2009 World Book Day Award longlist for The Bloomsday Dead 2010 Spinetingler Award for Best Novel for Fifty Grand 2011 Theakston Old Peculier Crime Novel of the Year Award longlist for Fifty Grand 2013 Spinetingler Award for Best Crime Novel for The Cold Cold Ground 2013 Prix Du Meilleur Polar shortlist for The Cold Cold Ground 2013 Crime Fest Last Laugh Award shortlist for The Cold Cold Ground 2013 Ned Kelly Award for Best Crime Novel shortlist for I Hear the Sirens in the Street 2014 Barry Award (for crime novels)for Best Mystery Novel (Paperback Original) for I Hear the Sirens in the Street 2014 Grand Prix de Littérature Policière shortlist for I Hear the Sirens in the Street 2014 Theakston Old Peculier Crime Novel of the Year Award shortlist for I Hear the Sirens in the Street 2014 Ned Kelly Award for Best Fiction for In the Morning I'll Be Gone 2015 Audie Award For Best Thriller shortlist for In the Morning I'll Be Gone 2015 Prix SNCF Du Polar shortlist for The Cold Cold Ground 2015 Ned Kelly Award shortlist for Gun Street Girl 2015 Boston Globe Best Book of 2015 for Gun Street Girl 2015 Irish Times Best Crime Novel of 2015 for Gun Street Girl 2016 Edgar Award (Best Paperback Original) shortlist for Gun Street Girl 2016 Anthony Award (Best Paperback Original) shortlist for Gun Street Girl 2016 Audie Award for Best Mystery shortlist for Gun Street Girl 2016 Boston Globe Best Book of 2016 for Rain Dogs 2016 Irish Times Best Crime Novel of 2016 for Rain Dogs 2016 Theakston Old Peculier Crime Novel of the Year Award shortlist for Rain Dogs 2016 Ned Kelly Award shortlist for Rain Dogs 2016 CWA Ian Fleming Steel Dagger shortlist for Rain Dogs 2017 Edgar Award (Best Paperback Original) for Rain Dogs 2017 Barry Award for Rain Dogs 2017 Anthony Award (Best Paperback Original) for Rain Dogs 2017 Ned Kelly Award for Police at the Station and They Don't Look Friendly 2017 CWA Ian Fleming Steel Dagger Award shortlist for Police at the Station and They Don't Look Friendly 2017 Boston Globe Best Book of 2017 for Police at the Station and They Don't Look Friendly 2018 International Thriller Writers Awards (Best Paperback Original Novel) shortlist for Police at the Station and They Don't Look Friendly 2019 Time magazine Books of the Year for The Chain 2020 Theakston's Old Peculier Crime Novel of the Year Award 2020 winner for The Chain. 2020 Ian Fleming Steel Dagger Award longlist for The Chain; CWA Body in the Library longlist for The Chain 2020 International Thriller Writers Award for Best Hardcover Novel, The Chain. 2020 Ned Kelly Award for Best International Crime Fiction for The Chain. 2020 Macavity Awards for Best Mystery Novel by Mystery Readers International for The Chain. 2020 Barry Award (for crime novels) for Best Mystery Novel winner for The Chain. 2022 In The Morning I'll Be Gone winner of the Prix Polar Pourpres for Best Mystery Novel 2022 Best Thrillers of 2022 for The Island. New York Times 2023 Best Thrillers of 2023 for The Detective Up Late. Washington Post 2024 Barry Award (for crime novels) nominee for Best Mystery Novel for The Detective Up Late
=== Max Braverman === Max Braverman (Max Burkholder) is Adam and Kristina's son (age 8 in the series pilot episode, although he is 14 in season 5) who is diagnosed with Asperger's syndrome at the beginning of the first season. His struggles and triumphs with this syndrome affect much of what happens in his family. Max is unaware of his diagnosis in the early episodes (although he is enthusiastic about participating in a "Walk for Autism"), but during the second season he learns about it after witnessing an argument between Adam and Crosby. His parents decide to transfer him to a mainstream school after being told that Max is very intelligent. In the season 2 finale, while at the hospital Max becomes very angry, saying that he wants pancakes more than he cares about Amber, even going as far as saying that doesn't care about her. Adam scolds Max for his hurtful comments, but Max believes he didn't do anything wrong, though at the end he apologizes to Sarah for what he said. In season 3, Max has been mainstreamed into a normal school, to challenge him academically. He is trying hard to make friends, though it proves difficult. He does make a friend in season 3, a boy with spina bifida named Micah, whose parents are thrilled because, like Max, he's never had a friend before. It is also discovered that Max is academically gifted. Though socially behind others his age, he is academically far above most others his age and older. In the fourth season, he is elected class president of Cedar Knoll Middle School with some help from his older sister Haddie.
Sources: en.wikipedia.org
Dewar's design was quickly transformed into a commercial item in 1904 as two German glassblowers, Reinhold Burger and Albert Aschenbrenner, discovered that it could be used to keep cold drinks cold and warm drinks warm and invented a more robust flask design, which was suited for everyday use. The Dewar flask design had never been patented but the German men who discovered the commercial use for the product named it Thermos, and subsequently claimed both the rights to the commercial product and the trademark to the name. In his subsequent attempt to claim the rights to the invention, Dewar instead lost a court case to the company. The manufacturing and performance of the Thermos bottle was significantly improved and refined by the Viennese inventor and merchant Gustav Robert Paalen, who designed various types for domestic use, which he also patented, and distributed widely, through the Thermos Bottle Companies in the United States, Canada and the UK, which bought licences for respective national markets. The American Thermos Bottle Company built up a mass production in Norwich, CT, which brought prices down and enabled the wide distribution of the product for at-home use. Over time, the company expanded the size, shapes and materials of these consumer products, primarily used for carrying coffee on the go and carrying liquids on camping trips to keep them either hot or cold. Eventually other manufacturers produced similar products for consumer use. The term "thermos" became a household name for vacuum flasks in general.
early production of insulin for treatment of Australian diabetics (1923) development of a tetanus vaccine (1938) development of a combined vaccine for diphtheria, tetanus and whooping cough (1953) rapid adoption and production of a polio vaccine (1956) development of a multi-purpose animal vaccine covering pulpy kidney (enterotoxemia), tetanus, black disease, malignant oedema and blackleg (1961) production of Rhesus (D) immunoglobulin to prevent haemolytic disease in newborns due to Rh factor incompatibility (1966–67) pioneering heat treatment to protect blood and plasma products from infection with HIV (1983) collaboration on development of the world's first human papillomavirus vaccine, Gardasil, building on the pioneering work by Professor Ian Frazer (1994–2005).
You cain’t get a man out by cussin’ him out." In the fall of 1998, Mizell had a heart attack while watching his son Dave coach High Point Andrews High School in a football game against North Davidson High School in Welcome. Four months later, on February 21, 1999, Mizell died at the age of 68 in Kerrville, Texas, where he was visiting his wife's family. In moving to have Mizell's obituary recorded in the Congressional Record, Senator Helms observed, "One doesn’t lose a friend like Wilmer Mizell without experiencing a deep and penetrating sadness." His burial site was the Faith Missionary Alliance Church Cemetery in Winston-Salem.
Sources: en.wikipedia.org
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.
Reported human trials are few, brief and originate mainly from one country. They describe effects on anxiety-related measures, but sample sizes are small and reporting is limited. The results are widely regarded as preliminary rather than confirmed.
Reverse-phase liquid chromatography is used to assess purity and separation of related impurities. Mass spectrometry confirms that the observed molecular mass matches the expected peptide. A certificate of analysis from the supplier is the usual document of record.
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.